PUBLISHER: Acute Market Reports | PRODUCT CODE: 1572339
PUBLISHER: Acute Market Reports | PRODUCT CODE: 1572339
Drug Discovery Informatics Market - Growth, Future Prospects and Competitive Analysis, 2024 - 2032
The drug discovery informatics market is a specialized segment within the pharmaceutical and biotechnology industries, focusing on the use of information technology and computational tools to support and enhance the process of drug discovery. This field encompasses a range of activities such as data mining, data analysis, in silico modeling, and simulation to identify potential new drugs and understand their properties and interactions. Drug discovery informatics market is estimated to grow at a CAGR of 11.5% from 2024 to 2032, due to the increasing demand for new drugs and the need for more efficient and cost-effective drug discovery processes. The rapid advancements in computational technology, along with the growing availability of biological and chemical data, have made informatics an integral part of drug discovery. Informatics tools in drug discovery help in managing large datasets, predicting drug targets, understanding drug interactions with biological systems, and reducing the time and cost associated with traditional drug discovery methods. The field integrates aspects of chemistry, biology, and computer science to facilitate the drug discovery process from initial screening of compounds to pre-clinical trials.
Driver: Advancements in Computational Technology
The growth of the drug discovery informatics market is principally driven by advancements in computational technology. The exponential increase in computational power and data storage capabilities has revolutionized the drug discovery process. Modern informatics tools enable researchers to efficiently manage and analyze large datasets, simulate drug interactions at the molecular level, and predict pharmacological outcomes with greater accuracy. These advancements are critical in identifying potential new drug candidates and understanding their mechanisms of action. Furthermore, computational methods such as molecular modeling, high-throughput screening, and bioinformatics have significantly reduced the time and cost associated with the early stages of drug discovery. The integration of advanced computing, such as quantum computing and AI algorithms, into drug discovery processes has the potential to uncover novel therapeutic targets and drug candidates that may have been previously overlooked or unfeasible to identify through traditional methods.
Opportunity: Emergence of AI and Machine Learning
An emerging opportunity in the drug discovery informatics market lies in the integration of artificial intelligence (AI) and machine learning. These technologies hold the potential to transform drug discovery by enabling more accurate predictive modeling, optimizing drug design, and accelerating the identification of promising drug candidates. AI algorithms can analyze vast amounts of biological data to uncover hidden patterns and insights, facilitating the discovery of new drug targets and biomarkers. Machine learning models can also predict the efficacy and safety profiles of compounds, thus streamlining the drug development pipeline. The incorporation of AI and machine learning into drug discovery informatics is not only enhancing the efficiency of the drug discovery process but also opening new avenues for personalized medicine, where treatments can be tailored to individual genetic profiles and disease pathways.
Restraint: Data Integration and Management Challenges
A significant restraint in the drug discovery informatics market is the challenge associated with data integration and management. The drug discovery process generates vast amounts of heterogeneous data, including chemical properties, biological activity, genomic data, and clinical trial results. Integrating and managing these diverse data types from various sources can be complex and resource-intensive. Ensuring data quality, consistency, and compatibility across different platforms and systems is a major challenge. Additionally, the need to handle sensitive and proprietary data securely adds another layer of complexity in terms of data governance and compliance with regulatory standards.
Challenges: Need for Specialized Expertise and Data Security
One of the key challenges facing the drug discovery informatics market is the need for specialized expertise and concerns regarding data security. The field requires a unique combination of skills in biology, chemistry, computer science, and data analytics. The shortage of professionals with this interdisciplinary knowledge can hinder the effective implementation and utilization of informatics tools in drug discovery. Moreover, as drug discovery informatics relies heavily on digital platforms, it faces significant risks related to data security and privacy. Protecting sensitive data from cyber threats and ensuring compliance with data protection regulations is crucial. These challenges underscore the need for robust cybersecurity measures and ongoing training to equip professionals with the necessary skills to navigate the complexities of drug discovery informatics.
Market Segmentation by Workflow
In the drug discovery informatics market, segmentation by workflow includes Discovery Informatics and Biocontent Management. The Discovery Informatics segment is anticipated to exhibit the highest Compound Annual Growth Rate (CAGR) from 2024 to 2032. This growth is driven by the increasing adoption of informatics solutions in the early stages of drug discovery, including target identification, validation, and compound screening. The advancements in computational tools and algorithms have significantly enhanced the efficiency of discovery informatics, making it a critical component in accelerating the drug development process. Despite the rapid growth of the Discovery Informatics segment, Biocontent Management generated the highest revenue in 2023. This is attributed to the growing need for efficient management of vast biological data generated during drug discovery processes. The emphasis on biocontent management reflects the industry's focus on leveraging data to gain deeper insights into drug interactions, mechanism of action, and safety profiles.
Market Segmentation by Services
Regarding market segmentation by services, the categories include Sequence Analysis Platforms, Molecular Modelling, Docking, Clinical Trial Data Management, and Others. The Molecular Modelling segment is expected to witness the highest CAGR from 2024 to 2032, driven by its crucial role in understanding molecular interactions, optimizing lead compounds, and predicting drug efficacy and toxicity. The increasing sophistication of molecular modelling tools, coupled with the integration of AI and machine learning, contributes to this growth. However, in 2023, the highest revenue was observed in the Clinical Trial Data Management service. This service's dominance is due to the critical importance of managing and analyzing clinical trial data effectively to ensure regulatory compliance, data integrity, and efficient trial management. The demand in this sector is bolstered by the increasing number of clinical trials globally and the growing complexity of clinical data.
Market Segmentation by Region
In the drug discovery informatics market, geographic segmentation highlights significant trends and growth prospects across different regions. The North American region, particularly the United States, generated the highest revenue in 2023 and is expected to continue leading the market from 2024 to 2032. This dominance is largely attributed to the strong presence of major pharmaceutical and biotechnology companies, significant investments in drug discovery and development, and the rapid adoption of advanced informatics technologies in the region. Additionally, North America's advanced healthcare infrastructure and substantial funding for research and development activities play a crucial role in its market leadership. The Asia-Pacific region, however, is projected to exhibit the highest Compound Annual Growth Rate (CAGR) during the same period. This growth can be attributed to the increasing investment in the pharmaceutical sector, the expansion of research and development facilities, and the growing emphasis on drug discovery initiatives in countries like China, Japan, and India. The region's burgeoning biotechnology industry and government support for healthcare innovation further fuel this growth.
Competitive Trends
Regarding competitive trends and key players, the market in 2023 was marked by the strong performance of companies like Certara, Boehringer Ingelheim International GmbH, Infosys Ltd., Charles River Laboratories, Collaborative Drug Discovery, Inc., Eurofins DiscoverX Products, Jubliant Biosys, Selvita, Novo Informatics Pvt. Ltd., ChemAxon Ltd., Albany Molecular Research Inc., Oracle, Accenture, Agilent Technologies, Inc., and Illumina, Inc. These companies have been instrumental in driving the market forward, leveraging their expertise in advanced analytics, machine learning, and molecular modeling. IBM's foray into AI-driven drug discovery, Schrodinger's advanced computational platforms, PerkinElmer's informatics solutions, and BIOVIA's integrated scientific software have set them apart in the industry. From 2024 to 2032, these market leaders are expected to focus on integrating AI and machine learning more deeply into their offerings, expanding their cloud-based services, and forming strategic partnerships to enhance their product portfolios and market reach. The emphasis is likely to be on developing more user-friendly, efficient, and cost-effective informatics solutions that cater to the evolving needs of drug discovery and development processes. The combined revenue of these companies in 2023 reflects their significant market presence, and their strategies are anticipated to significantly influence market dynamics over the forecast period, highlighting the market's drive towards innovation, technological integration, and strategic collaborations.
Historical & Forecast Period
This study report represents an analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.
The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Drug Discovery Informatics market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users & consumption volume, price, and value.
Geographical revenues generated by countries considered in the report
Micro and macro environment factors that are currently influencing the Drug Discovery Informatics market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.
Market Segmentation
Workflow
- Discovery Informatics
- Biocontent Management
Services
- Sequence Analysis Platforms
- Molecular Modelling
- Docking
- Clinical Trial Data Management
- Others
Region Segment (2022-2032; US$ Million)
North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Key questions answered in this report
What are the key micro and macro environmental factors that are impacting the growth of Drug Discovery Informatics market?
What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2032.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Drug Discovery Informatics market?
Which is the largest regional market for Drug Discovery Informatics market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Which are the key trends driving Drug Discovery Informatics market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Drug Discovery Informatics market worldwide?
Table of Contents
1. Preface
- 1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted
2. Executive Summary
- 2.1. Market Snapshot: Global Drug Discovery Informatics Market
- 2.2. Global Drug Discovery Informatics Market, By Workflow, 2023 (US$ Million)
- 2.3. Global Drug Discovery Informatics Market, By Services, 2023 (US$ Million)
- 2.4. Global Drug Discovery Informatics Market, By Geography, 2023 (US$ Million)
- 2.5. Attractive Investment Proposition by Geography, 2023
3. Drug Discovery Informatics Market: Competitive Analysis
- 3.1. Market Positioning of Key Drug Discovery Informatics Market Vendors
- 3.2. Strategies Adopted by Drug Discovery Informatics Market Vendors
- 3.3. Key Industry Strategies
- 3.4. Tier Analysis 2023 Versus 2032
4. Drug Discovery Informatics Market: Macro Analysis & Market Dynamics
- 4.1. Introduction
- 4.2. Global Drug Discovery Informatics Market Value, 2022 - 2032, (US$ Million)
- 4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
- 4.4. Impact Analysis of Drivers and Restraints
- 4.5. See-Saw Analysis
- 4.6. Porter's Five Force Model
- 4.6.1. Supplier Power
- 4.6.2. Buyer Power
- 4.6.3. Threat Of Substitutes
- 4.6.4. Threat Of New Entrants
- 4.6.5. Competitive Rivalry
- 4.7. PESTEL Analysis
- 4.7.1. Political Landscape
- 4.7.2. Economic Landscape
- 4.7.3. Technology Landscape
- 4.7.4. Legal Landscape
- 4.7.5. Social Landscape
5. Drug Discovery Informatics Market: By Workflow, 2022-2032, USD (Million)
- 5.1. Market Overview
- 5.2. Growth & Revenue Analysis: 2023 Versus 2032
- 5.3. Market Segmentation
- 5.3.1. Discovery Informatics
- 5.3.2. Biocontent Management
6. Drug Discovery Informatics Market: By Services, 2022-2032, USD (Million)
- 6.1. Market Overview
- 6.2. Growth & Revenue Analysis: 2023 Versus 2032
- 6.3. Market Segmentation
- 6.3.1. Sequence Analysis Platforms
- 6.3.2. Molecular Modelling
- 6.3.3. Docking
- 6.3.4. Clinical Trial Data Management
- 6.3.5. Others
7. North America Drug Discovery Informatics Market, 2022-2032, USD (Million)
- 7.1. Market Overview
- 7.2. Drug Discovery Informatics Market: By Workflow, 2022-2032, USD (Million)
- 7.3. Drug Discovery Informatics Market: By Services, 2022-2032, USD (Million)
- 7.4.Drug Discovery Informatics Market: By Region, 2022-2032, USD (Million)
- 7.4.1.North America
- 7.4.1.1. U.S.
- 7.4.1.1.1. Drug Discovery Informatics Market: By Workflow, 2022-2032, USD (Million)
- 7.4.1.1.2. Drug Discovery Informatics Market: By Services, 2022-2032, USD (Million)
- 7.4.1.2. Canada
- 7.4.1.2.1. Drug Discovery Informatics Market: By Workflow, 2022-2032, USD (Million)
- 7.4.1.2.2. Drug Discovery Informatics Market: By Services, 2022-2032, USD (Million)
- 7.4.1.3. Rest of North America
- 7.4.1.3.1. Drug Discovery Informatics Market: By Workflow, 2022-2032, USD (Million)
- 7.4.1.3.2. Drug Discovery Informatics Market: By Services, 2022-2032, USD (Million)
- 7.4.1.1. U.S.
- 7.4.1.North America
8. UK and European Union Drug Discovery Informatics Market, 2022-2032, USD (Million)
- 8.1. Market Overview
- 8.2. Drug Discovery Informatics Market: By Workflow, 2022-2032, USD (Million)
- 8.3. Drug Discovery Informatics Market: By Services, 2022-2032, USD (Million)
- 8.4.Drug Discovery Informatics Market: By Region, 2022-2032, USD (Million)
- 8.4.1.UK and European Union
- 8.4.1.1. UK
- 8.4.1.1.1. Drug Discovery Informatics Market: By Workflow, 2022-2032, USD (Million)
- 8.4.1.1.2. Drug Discovery Informatics Market: By Services, 2022-2032, USD (Million)
- 8.4.1.2. Germany
- 8.4.1.2.1. Drug Discovery Informatics Market: By Workflow, 2022-2032, USD (Million)
- 8.4.1.2.2. Drug Discovery Informatics Market: By Services, 2022-2032, USD (Million)
- 8.4.1.3. Spain
- 8.4.1.3.1. Drug Discovery Informatics Market: By Workflow, 2022-2032, USD (Million)
- 8.4.1.3.2. Drug Discovery Informatics Market: By Services, 2022-2032, USD (Million)
- 8.4.1.4. Italy
- 8.4.1.4.1. Drug Discovery Informatics Market: By Workflow, 2022-2032, USD (Million)
- 8.4.1.4.2. Drug Discovery Informatics Market: By Services, 2022-2032, USD (Million)
- 8.4.1.5. France
- 8.4.1.5.1. Drug Discovery Informatics Market: By Workflow, 2022-2032, USD (Million)
- 8.4.1.5.2. Drug Discovery Informatics Market: By Services, 2022-2032, USD (Million)
- 8.4.1.6. Rest of Europe
- 8.4.1.6.1. Drug Discovery Informatics Market: By Workflow, 2022-2032, USD (Million)
- 8.4.1.6.2. Drug Discovery Informatics Market: By Services, 2022-2032, USD (Million)
- 8.4.1.1. UK
- 8.4.1.UK and European Union
9. Asia Pacific Drug Discovery Informatics Market, 2022-2032, USD (Million)
- 9.1. Market Overview
- 9.2. Drug Discovery Informatics Market: By Workflow, 2022-2032, USD (Million)
- 9.3. Drug Discovery Informatics Market: By Services, 2022-2032, USD (Million)
- 9.4.Drug Discovery Informatics Market: By Region, 2022-2032, USD (Million)
- 9.4.1.Asia Pacific
- 9.4.1.1. China
- 9.4.1.1.1. Drug Discovery Informatics Market: By Workflow, 2022-2032, USD (Million)
- 9.4.1.1.2. Drug Discovery Informatics Market: By Services, 2022-2032, USD (Million)
- 9.4.1.2. Japan
- 9.4.1.2.1. Drug Discovery Informatics Market: By Workflow, 2022-2032, USD (Million)
- 9.4.1.2.2. Drug Discovery Informatics Market: By Services, 2022-2032, USD (Million)
- 9.4.1.3. India
- 9.4.1.3.1. Drug Discovery Informatics Market: By Workflow, 2022-2032, USD (Million)
- 9.4.1.3.2. Drug Discovery Informatics Market: By Services, 2022-2032, USD (Million)
- 9.4.1.4. Australia
- 9.4.1.4.1. Drug Discovery Informatics Market: By Workflow, 2022-2032, USD (Million)
- 9.4.1.4.2. Drug Discovery Informatics Market: By Services, 2022-2032, USD (Million)
- 9.4.1.5. South Korea
- 9.4.1.5.1. Drug Discovery Informatics Market: By Workflow, 2022-2032, USD (Million)
- 9.4.1.5.2. Drug Discovery Informatics Market: By Services, 2022-2032, USD (Million)
- 9.4.1.6. Rest of Asia Pacific
- 9.4.1.6.1. Drug Discovery Informatics Market: By Workflow, 2022-2032, USD (Million)
- 9.4.1.6.2. Drug Discovery Informatics Market: By Services, 2022-2032, USD (Million)
- 9.4.1.1. China
- 9.4.1.Asia Pacific
10. Latin America Drug Discovery Informatics Market, 2022-2032, USD (Million)
- 10.1. Market Overview
- 10.2. Drug Discovery Informatics Market: By Workflow, 2022-2032, USD (Million)
- 10.3. Drug Discovery Informatics Market: By Services, 2022-2032, USD (Million)
- 10.4.Drug Discovery Informatics Market: By Region, 2022-2032, USD (Million)
- 10.4.1.Latin America
- 10.4.1.1. Brazil
- 10.4.1.1.1. Drug Discovery Informatics Market: By Workflow, 2022-2032, USD (Million)
- 10.4.1.1.2. Drug Discovery Informatics Market: By Services, 2022-2032, USD (Million)
- 10.4.1.2. Mexico
- 10.4.1.2.1. Drug Discovery Informatics Market: By Workflow, 2022-2032, USD (Million)
- 10.4.1.2.2. Drug Discovery Informatics Market: By Services, 2022-2032, USD (Million)
- 10.4.1.3. Rest of Latin America
- 10.4.1.3.1. Drug Discovery Informatics Market: By Workflow, 2022-2032, USD (Million)
- 10.4.1.3.2. Drug Discovery Informatics Market: By Services, 2022-2032, USD (Million)
- 10.4.1.1. Brazil
- 10.4.1.Latin America
11. Middle East and Africa Drug Discovery Informatics Market, 2022-2032, USD (Million)
- 11.1. Market Overview
- 11.2. Drug Discovery Informatics Market: By Workflow, 2022-2032, USD (Million)
- 11.3. Drug Discovery Informatics Market: By Services, 2022-2032, USD (Million)
- 11.4.Drug Discovery Informatics Market: By Region, 2022-2032, USD (Million)
- 11.4.1.Middle East and Africa
- 11.4.1.1. GCC
- 11.4.1.1.1. Drug Discovery Informatics Market: By Workflow, 2022-2032, USD (Million)
- 11.4.1.1.2. Drug Discovery Informatics Market: By Services, 2022-2032, USD (Million)
- 11.4.1.2. Africa
- 11.4.1.2.1. Drug Discovery Informatics Market: By Workflow, 2022-2032, USD (Million)
- 11.4.1.2.2. Drug Discovery Informatics Market: By Services, 2022-2032, USD (Million)
- 11.4.1.3. Rest of Middle East and Africa
- 11.4.1.3.1. Drug Discovery Informatics Market: By Workflow, 2022-2032, USD (Million)
- 11.4.1.3.2. Drug Discovery Informatics Market: By Services, 2022-2032, USD (Million)
- 11.4.1.1. GCC
- 11.4.1.Middle East and Africa
12. Company Profile
- 12.1. Certara
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Portfolio
- 12.1.4. Strategic Initiatives
- 12.2. Boehringer Ingelheim International GmbH
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Portfolio
- 12.2.4. Strategic Initiatives
- 12.3. Infosys Ltd.
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Portfolio
- 12.3.4. Strategic Initiatives
- 12.4. Charles River Laboratories
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Portfolio
- 12.4.4. Strategic Initiatives
- 12.5. Collaborative Drug Discovery, Inc.
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Portfolio
- 12.5.4. Strategic Initiatives
- 12.6. Eurofins DiscoverX Products
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Portfolio
- 12.6.4. Strategic Initiatives
- 12.7. Jubliant Biosys
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Portfolio
- 12.7.4. Strategic Initiatives
- 12.8. Selvita
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Portfolio
- 12.8.4. Strategic Initiatives
- 12.9. Novo Informatics Pvt. Ltd.
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Portfolio
- 12.9.4. Strategic Initiatives
- 12.10. ChemAxon Ltd.
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Portfolio
- 12.10.4. Strategic Initiatives
- 12.11. Albany Molecular Research Inc.
- 12.11.1. Company Overview
- 12.11.2. Financial Performance
- 12.11.3. Product Portfolio
- 12.11.4. Strategic Initiatives
- 12.12. Oracle
- 12.12.1. Company Overview
- 12.12.2. Financial Performance
- 12.12.3. Product Portfolio
- 12.12.4. Strategic Initiatives
- 12.13. Accenture
- 12.13.1. Company Overview
- 12.13.2. Financial Performance
- 12.13.3. Product Portfolio
- 12.13.4. Strategic Initiatives
- 12.14. Agilent Technologies, Inc.
- 12.14.1. Company Overview
- 12.14.2. Financial Performance
- 12.14.3. Product Portfolio
- 12.14.4. Strategic Initiatives
- 12.15. Illumina, Inc.
- 12.15.1. Company Overview
- 12.15.2. Financial Performance
- 12.15.3. Product Portfolio
- 12.15.4. Strategic Initiatives
- 12.16. Other Notable Players
- 12.16.1. Company Overview
- 12.16.2. Financial Performance
- 12.16.3. Product Portfolio
- 12.16.4. Strategic Initiatives
List of Tables
- TABLE 1 Global Drug Discovery Informatics Market By Workflow, 2022-2032, USD (Million)
- TABLE 2 Global Drug Discovery Informatics Market By Services, 2022-2032, USD (Million)
- TABLE 3 North America Drug Discovery Informatics Market By Workflow, 2022-2032, USD (Million)
- TABLE 4 North America Drug Discovery Informatics Market By Services, 2022-2032, USD (Million)
- TABLE 5 U.S. Drug Discovery Informatics Market By Workflow, 2022-2032, USD (Million)
- TABLE 6 U.S. Drug Discovery Informatics Market By Services, 2022-2032, USD (Million)
- TABLE 7 Canada Drug Discovery Informatics Market By Workflow, 2022-2032, USD (Million)
- TABLE 8 Canada Drug Discovery Informatics Market By Services, 2022-2032, USD (Million)
- TABLE 9 Rest of North America Drug Discovery Informatics Market By Workflow, 2022-2032, USD (Million)
- TABLE 10 Rest of North America Drug Discovery Informatics Market By Services, 2022-2032, USD (Million)
- TABLE 11 UK and European Union Drug Discovery Informatics Market By Workflow, 2022-2032, USD (Million)
- TABLE 12 UK and European Union Drug Discovery Informatics Market By Services, 2022-2032, USD (Million)
- TABLE 13 UK Drug Discovery Informatics Market By Workflow, 2022-2032, USD (Million)
- TABLE 14 UK Drug Discovery Informatics Market By Services, 2022-2032, USD (Million)
- TABLE 15 Germany Drug Discovery Informatics Market By Workflow, 2022-2032, USD (Million)
- TABLE 16 Germany Drug Discovery Informatics Market By Services, 2022-2032, USD (Million)
- TABLE 17 Spain Drug Discovery Informatics Market By Workflow, 2022-2032, USD (Million)
- TABLE 18 Spain Drug Discovery Informatics Market By Services, 2022-2032, USD (Million)
- TABLE 19 Italy Drug Discovery Informatics Market By Workflow, 2022-2032, USD (Million)
- TABLE 20 Italy Drug Discovery Informatics Market By Services, 2022-2032, USD (Million)
- TABLE 21 France Drug Discovery Informatics Market By Workflow, 2022-2032, USD (Million)
- TABLE 22 France Drug Discovery Informatics Market By Services, 2022-2032, USD (Million)
- TABLE 23 Rest of Europe Drug Discovery Informatics Market By Workflow, 2022-2032, USD (Million)
- TABLE 24 Rest of Europe Drug Discovery Informatics Market By Services, 2022-2032, USD (Million)
- TABLE 25 Asia Drug Discovery Informatics Market By Workflow, 2022-2032, USD (Million)
- TABLE 26 Asia Drug Discovery Informatics Market By Services, 2022-2032, USD (Million)
- TABLE 27 China Drug Discovery Informatics Market By Workflow, 2022-2032, USD (Million)
- TABLE 28 China Drug Discovery Informatics Market By Services, 2022-2032, USD (Million)
- TABLE 29 Japan Drug Discovery Informatics Market By Workflow, 2022-2032, USD (Million)
- TABLE 30 Japan Drug Discovery Informatics Market By Services, 2022-2032, USD (Million)
- TABLE 31 India Drug Discovery Informatics Market By Workflow, 2022-2032, USD (Million)
- TABLE 32 India Drug Discovery Informatics Market By Services, 2022-2032, USD (Million)
- TABLE 33 Australia Drug Discovery Informatics Market By Workflow, 2022-2032, USD (Million)
- TABLE 34 Australia Drug Discovery Informatics Market By Services, 2022-2032, USD (Million)
- TABLE 35 South Korea Drug Discovery Informatics Market By Workflow, 2022-2032, USD (Million)
- TABLE 36 South Korea Drug Discovery Informatics Market By Services, 2022-2032, USD (Million)
- TABLE 37 Latin America Drug Discovery Informatics Market By Workflow, 2022-2032, USD (Million)
- TABLE 38 Latin America Drug Discovery Informatics Market By Services, 2022-2032, USD (Million)
- TABLE 39 Brazil Drug Discovery Informatics Market By Workflow, 2022-2032, USD (Million)
- TABLE 40 Brazil Drug Discovery Informatics Market By Services, 2022-2032, USD (Million)
- TABLE 41 Mexico Drug Discovery Informatics Market By Workflow, 2022-2032, USD (Million)
- TABLE 42 Mexico Drug Discovery Informatics Market By Services, 2022-2032, USD (Million)
- TABLE 43 Rest of Latin America Drug Discovery Informatics Market By Workflow, 2022-2032, USD (Million)
- TABLE 44 Rest of Latin America Drug Discovery Informatics Market By Services, 2022-2032, USD (Million)
- TABLE 45 Middle East and Africa Drug Discovery Informatics Market By Workflow, 2022-2032, USD (Million)
- TABLE 46 Middle East and Africa Drug Discovery Informatics Market By Services, 2022-2032, USD (Million)
- TABLE 47 GCC Drug Discovery Informatics Market By Workflow, 2022-2032, USD (Million)
- TABLE 48 GCC Drug Discovery Informatics Market By Services, 2022-2032, USD (Million)
- TABLE 49 Africa Drug Discovery Informatics Market By Workflow, 2022-2032, USD (Million)
- TABLE 50 Africa Drug Discovery Informatics Market By Services, 2022-2032, USD (Million)
- TABLE 51 Rest of Middle East and Africa Drug Discovery Informatics Market By Workflow, 2022-2032, USD (Million)
- TABLE 52 Rest of Middle East and Africa Drug Discovery Informatics Market By Services, 2022-2032, USD (Million)
List of Figures
- FIG. 1 Global Drug Discovery Informatics Market: Market Coverage
- FIG. 2 Research Methodology and Data Sources
- FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
- FIG. 4 Global Drug Discovery Informatics Market: Quality Assurance
- FIG. 5 Global Drug Discovery Informatics Market, By Workflow, 2023
- FIG. 6 Global Drug Discovery Informatics Market, By Services, 2023
- FIG. 7 Global Drug Discovery Informatics Market, By Geography, 2023
- FIG. 8 Market Geographical Opportunity Matrix - Global Drug Discovery Informatics Market, 2023
FIG. 9Market Positioning of Key Drug Discovery Informatics Market Players, 2023
FIG. 10Global Drug Discovery Informatics Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032
- FIG. 11 Global Drug Discovery Informatics Market, By Workflow, 2023 Vs 2032, %
- FIG. 12 Global Drug Discovery Informatics Market, By Services, 2023 Vs 2032, %
- FIG. 13 U.S. Drug Discovery Informatics Market (US$ Million), 2022 - 2032
- FIG. 14 Canada Drug Discovery Informatics Market (US$ Million), 2022 - 2032
- FIG. 15 Rest of North America Drug Discovery Informatics Market (US$ Million), 2022 - 2032
- FIG. 16 UK Drug Discovery Informatics Market (US$ Million), 2022 - 2032
- FIG. 17 Germany Drug Discovery Informatics Market (US$ Million), 2022 - 2032
- FIG. 18 Spain Drug Discovery Informatics Market (US$ Million), 2022 - 2032
- FIG. 19 Italy Drug Discovery Informatics Market (US$ Million), 2022 - 2032
- FIG. 20 France Drug Discovery Informatics Market (US$ Million), 2022 - 2032
- FIG. 21 Rest of Europe Drug Discovery Informatics Market (US$ Million), 2022 - 2032
- FIG. 22 China Drug Discovery Informatics Market (US$ Million), 2022 - 2032
- FIG. 23 Japan Drug Discovery Informatics Market (US$ Million), 2022 - 2032
- FIG. 24 India Drug Discovery Informatics Market (US$ Million), 2022 - 2032
- FIG. 25 Australia Drug Discovery Informatics Market (US$ Million), 2022 - 2032
- FIG. 26 South Korea Drug Discovery Informatics Market (US$ Million), 2022 - 2032
- FIG. 27 Rest of Asia Drug Discovery Informatics Market (US$ Million), 2022 - 2032
- FIG. 28 Brazil Drug Discovery Informatics Market (US$ Million), 2022 - 2032
- FIG. 29 Mexico Drug Discovery Informatics Market (US$ Million), 2022 - 2032
- FIG. 30 Rest of Latin America Drug Discovery Informatics Market (US$ Million), 2022 - 2032
- FIG. 31 GCC Drug Discovery Informatics Market (US$ Million), 2022 - 2032
- FIG. 32 Africa Drug Discovery Informatics Market (US$ Million), 2022 - 2032
- FIG. 33 Rest of Middle East and Africa Drug Discovery Informatics Market (US$ Million), 2022 - 2032
